Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer
- PMID: 24798166
- PMCID: PMC5746183
- DOI: 10.1097/PAT.0000000000000097
Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer
Abstract
Based on revisions of Gleason scoring in 2005, it has been reported that nodal metastases at radical prostatectomy in Gleason 3 + 3 = 6 (GS6) prostate cancer are extremely rare, and that GS6 cancers with nodal metastases are invariably upgraded upon review by academic urological pathologists. We analysed the prevalence and determinants of nodal metastases in a national sample of patients with GS6 cancer.We utilised the SEER database to identify patients diagnosed with GS6 prostate cancer during 2004-2010 who had radical prostatectomy and ≥1 lymph node(s) examined. We calculated the prevalence of nodal metastases and constructed a multivariable logistic regression model to identify factors associated with nodal metastases. Among 21,960 patients, the prevalence of nodal metastases was 0.48%. Older age, preoperative PSA >10 ng/mL, and advanced stage were positively associated with nodal metastases. Lymph node metastases in GS6 cancer are more prevalent in a nationwide population compared to academic centres. Revised guidelines for Gleason scoring have made GS6 cancer a more homogeneously indolent disease, which may be relevant in the era of active surveillance. We submit that lymph node metastases in GS6 cancer be used as a proxy for adherence to the 2005 ISUP consensus on Gleason grading.
Conflict of interest statement
Figures
Comment in
-
Re: Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer.Pathology. 2015 Jun;47(4):394. doi: 10.1097/PAT.0000000000000263. Pathology. 2015. PMID: 25938366 No abstract available.
-
Re: Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer: authors' reply.Pathology. 2015 Jun;47(4):394-5. doi: 10.1097/PAT.0000000000000264. Pathology. 2015. PMID: 25938367 No abstract available.
References
-
- Bailar JC, Mellinger GT, Gleason DF. Survival rates of patients with prostatic cancer, tumor stage, and differentiation—preliminary report. Cancer Chemother Rep. 1966;50:129–36. - PubMed
-
- Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50:125–8. - PubMed
-
- Epstein JI, Allsbrook WC, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228–42. - PubMed
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2012 Sub (1973–2010 varying) Linked To County Attributes – Total US, 1969–2011 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. released April 2013, based on the November 2012 submission. www.seer.cancer.gov.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous